BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1600040)

  • 1. Circadian differences in pharmacological blockade of meal-stimulated gastric acid secretion.
    Sanders SW; Moore JG; Day GM; Tolman KG
    Aliment Pharmacol Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1600040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
    Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
    Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.
    Prewett EJ; Hudson M; Nwokolo CU; Sawyerr AM; Pounder RE
    Gastroenterology; 1991 Apr; 100(4):873-7. PubMed ID: 2001826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
    Blum RA; Shi H; Karol MD; Greski-Rose PA; Hunt RH
    Clin Ther; 1997; 19(5):1013-23. PubMed ID: 9385488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
    Hurlimann S; Abbühl B; Inauen W; Halter F
    Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine.
    van Herwaarden MA; Samsom M; van Nispen CH; Mulder PG; Smout AJ
    Aliment Pharmacol Ther; 1999 Jun; 13(6):731-40. PubMed ID: 10383501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
    J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH.
    Khoury RM; Katz PO; Hammod R; Castell DO
    Aliment Pharmacol Ther; 1999 May; 13(5):675-8. PubMed ID: 10233192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
    Peghini PL; Katz PO; Castell DO
    Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four-hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placebo.
    Houben GM; Hooi J; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 1995 Dec; 9(6):649-54. PubMed ID: 8824652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gastric feeding on intragastric P(CO2) tonometry in healthy volunteers.
    Kolkman JJ; Groeneveld AB; Meuwissen SG
    J Crit Care; 1999 Mar; 14(1):34-8. PubMed ID: 10102722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
    Kiilerich S; Rannem T; Elsborg L
    Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
    Hedenström H; Alm C; Kraft M; Grahnén A
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
    Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
    Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragastric pH and pharmacokinetics of intravenous ranitidine during sinusoidal and constant-rate infusions.
    Sanders SW; Bishop AL; Moore JG
    Chronobiol Int; 1991; 8(4):267-76. PubMed ID: 1797416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
    Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers.
    Khoury RM; Katz PO; Castell DO
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1211-4. PubMed ID: 10468703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects.
    Fraser AG; Sawyerr AM; Hudson M; Smith MS; Pounder RE
    Aliment Pharmacol Ther; 1996 Aug; 10(4):523-7. PubMed ID: 8853755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine.
    Merki HS; Halter F; Wilder-Smith CH
    Gastroenterology; 1993 Sep; 105(3):748-54. PubMed ID: 8103027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers.
    Dammann HG; Burkhardt F; Wolf N
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1195-203. PubMed ID: 10468701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.